According to the research report titled ‘Global Molecular Imaging Market 2022-2028’, available with MarketStudyReport, global molecular imaging market is poised to grow by USD 12,165 million by the year 2028, expanding at 5.9% CAGR during the analysis timeframe.

Technological breakthroughs, increasing disposable income, and the rising prevalence of chronic disorders are some of the key factors driving the growth of the global molecular imaging market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042736/  

For those unaware, molecular imaging is a field of medical imaging which focuses on imaging molecules of medical interest in living patients. These procedures are known to be non-invasive, safe, and painless as well as diagnose and manage the treatment of cancer, heart disease, and brain disorders among others.

The research report on the ‘global molecular imaging market’ provides an in-depth analysis of the historical and the ongoing trends as well as growth drivers, challenges & restraints, and other expansion avenues. It provides an exclusive insight into the market size, share, and volume and highlights the competitive landscape. This study also provides an analysis of the COVID-19 impact on the overall industry outlook.

The report offers past data and future estimates of the various market segmentations such as end-user spectrum, component type, application scope, and regional contribution.

Based on the component type, the market is divided into imaging systems, imaging software, and imaging agents. Among these, the imaging systems segment is further categorized into multimodality imaging, magnetic resonance spectroscopy,
radionuclide imaging, optical imaging, and ultrasound molecular imaging. The multimodality imaging segment accounted for the largest market share in 2021 and is likely to depict similar growth patterns in the subsequent years.

Meanwhile, the imaging agent segments are categorized into antibodies, small molecules aptamers, and peptides. Out of these, the peptides segment is anticipated to account for the largest market over the forecast timeline

Moving on to the application spectrum, the market is fragmented into preclinical research and clinical applications. Citing the end-user landscape, the market is segmented into specialty clinics, hospitals, ambulatory surgical centers (ASCs), and others.

The regional segmentation of this business space extends to Asia Pacific, North America, Europe, and the Rest of the World.

Bayer AG, Canon Medical Systems Corporation, CMR Naviscan Corporation, Digirad Corporation, DDD-Diagnostic A/S, Cardinal Health Inc., Bruker Corporation, Spectrum Dynamics Medical Inc., United Imaging Healthcare Co. Ltd., MiE Medical Imaging Electronics GmbH, Mediso Ltd., Koninklijke Philips N.V., Guerbet SA, Esaote S.p.A GE Healthcare, PerkinElmer Inc., Novartis International AG, Neusoft Corporation, Vieworks Co. Ltd., Siemens Healthineers AG, and Shimadzu Corporation are some of the major companies influencing the competitive landscape of the global molecular imaging market.